Full Text View
Tabular View
No Study Results Posted
Related Studies
Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
This study is currently recruiting participants.
Study NCT00445913   Information provided by University of Pittsburgh
First Received: March 7, 2007   Last Updated: November 1, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 1 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
control dendritic cells
Sponsors listed in this trial
University of Pittsburgh


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services